復宏漢霖據報與強生等就授權談判
彭博社引述消息報道,復宏漢霖(2696)與強生和羅氏等跨國製藥公司就出售一款實驗性抗癌藥物的相關權利進行會談。
Last Update:
16 9 月, 2025
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.